MPXOF - MPX International Announces that its Maltese Subsidiary Alphafarma Operations Ltd. Receives eu-gmp Certification
(TheNewswire)
TORONTO, ONTARIO – TheNewswire- January 12, 2022 – MPX International Corporation (“ MPXInternational ”, “ MPXI ” or the“ Corporation ”) (CSE:MPXI )(CNSX:MPXI.CN) ( OTC:MPXOF), a multinational diversifiedcannabis company, is pleased to announce that its indirect subsidiary,Alphafarma Operations Ltd. (“ Alphafarma ”) has received European UnionGood Manufacturing Practices certification (the “ EU-GMP Certification ”) from the Medicines Authority of Malta (“ MMA ”) for itsfacility located in Birkirkara, Malta to finish dried cannabis flowerin jars for medicinal use.
EU-GMP Certification is the highest standard forpharmaceutical production in the world and it is issued by adesignated competent authority in Europe to pharmaceutical facilitiesthat have passed a rigorous regulatory inspection process. P ending the receipt of the manufacturinglicense to be issued by the MMA for the production of cannabis formedicinal and research purposes (the “Cannabis License” ), this certification will allowAlphafarma to begin processing and exporting medical cannabis flowerfrom Malta into markets across Europe and elsewhere . Alphafarma has negotiated afavourable supply agreement with a licensed producer of cannabisflower which will be supplemented with additional biomass from itsSouth African-based cultivation facility, likely in late 2023.
Through this certification, MPXI will be one of thevery few companies with an EU-GMP certified cannabis facility which isactually located in the European marketplace. Alphafarma will also use the foundations established by the EU-GMPCertification process to imminently apply for a license amendment toprocess cannabis extracts, thus providing patients and prescriberswith a wide portfolio of medical cannabis products of the highestquality, safety and efficacy standards.
“EU-GMP certification is a significant milestone forMPXI’s operations in Europe and MPXI’s international growthstrategy. Our team in Malta has been exceptional in its pursuant ofthis certification and is well positioned for the next phase which isthe export of cannabis flower to Europe,” said W. Scott Boyes,Chairman, President and CEO of MPXI. “This achievement reinforcesour plans to create a global cannabis company. Once Alphafarmareceives its manufacturing license, MPXI will be unique as the onlycannabis company with revenue generating operations in North America,Europe and Asia, which MPXI believes will to additional strategicopportunities.”
About MPX InternationalCorporation
MPX International Corporation is a multinational diversified cannabis company focused on developing and operating assets across theinternational cannabis industry with an emphasis on cultivating,manufacturing and marketing products which include cannabinoids astheir primary active ingredient. With current operations spanning fourcontinents in Canada, Switzerland, South Africa, Malta, Australia andThailand as well as evolving partnership and distributionopportunities in other jurisdictions, MPXI continues to positionitself as an emergent global participant in the cannabisindustry.
Cautionary Statement RegardingForward-Looking Information
This news release includes certain“forward-looking statements” under applicable Canadian securitieslegislation that are not historical facts. Forward-looking statementsinvolve risks, uncertainties, and other factors that could causeactual results, performance, prospects, and opportunities to differmaterially from those expressed or implied by such forward-lookingstatements. Forward-looking statements in this news release include,but are not limited to, MPX International’s objectives andintentions. Forward-looking statements are necessarily based on anumber of estimates and assumptions that, while considered reasonable,are subject to known and unknown risks, uncertainties and otherfactors which may causeactual results and future events to differ materially from thoseexpressed or implied by such forward-looking statements. Such factorsinclude, but are not limited to: general business, economic and socialuncertainties; litigation, legislative, environmental and otherjudicial, regulatory, political and competitive developments; delay orfailure to receive board, shareholder or regulatory approvals; theCorporation’s ability to effectively deal with the restrictions,limitations and health issues presented by the COVID-19 pandemic;future cannabis pricing; cannabis cultivation yields; costs of inputs;its ability to market products successfully to its anticipatedclients; reliance on key personnel and contracted relationships withthird parties; the regulatory environment in Australia, Canada, Malta,South Africa, Switzerland and other international jurisdictions; theability to complete any future potential transactions and the termsand conditions thereof; the application of federal, state, provincial,county and municipal laws; and the impact of increasing competition; those additional risks setout in MPX International’s public documents filed on SEDARat www.sedar.com , including its audited annualconsolidated financial statements for the financial years endedSeptember 30, 2020 and 2019, and the corresponding management’sdiscussion and analysis; and other matters discussed in this newsrelease. Although MPX International believes that the assumptions andfactors used in preparing the forward-looking statements arereasonable, undue reliance should not be placed on these statements,which only apply as of the date of this news release, and no assurancecan be given that such events will occur in the disclosed time framesor at all. Except where required by law, MPX International disclaimsany intention or obligation to update or revise any forward-lookingstatement, whether as a result of new information, future events, orotherwise.
For further information about MPXI,please contact:
MPX International Corporation
W. Scott Boyes, Chairman, President andCEO
T: +1-416-840-4703
E: , info@mpxinternationalcorp.com
or visit one our websites:
NOT FOR DISTRIBUTION TONEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THEUNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAYCONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS.
Copyright (c) 2022 TheNewswire - All rights reserved.